Found: 13
Select item for more details and to access through your institution.
Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091928
- By:
- Publication type:
- Article
Characterization and Stabilization of a New 64 Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 67, doi. 10.3390/pharmaceutics14010067
- By:
- Publication type:
- Article
Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225 Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 10, p. 1706, doi. 10.3390/pharmaceutics13101706
- By:
- Publication type:
- Article
64 Cu 2+ Complexes of Tripodal Amine Ligands' In Vivo Tumor and Liver Uptakes and Intracellular Cu Distribution in the Extrahepatic Bile Duct Carcinoma Cell Line TFK-1: A Basic Comparative Study.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 7, p. 820, doi. 10.3390/ph17070820
- By:
- Publication type:
- Article
Trace Metal Impurities Effects on the Formation of [ 64 Cu]Cu-diacetyl-bis(N 4 -methylthiosemicarbazone) ([ 64 Cu]Cu-ATSM).
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 1, p. 10, doi. 10.3390/ph17010010
- By:
- Publication type:
- Article
Process to Remove the Size Variants Contained in the Antibody–Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 10, p. 1341, doi. 10.3390/ph16101341
- By:
- Publication type:
- Article
Evaluation of 64 Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 10, p. 950, doi. 10.3390/ph14100950
- By:
- Publication type:
- Article
In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64 Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5807, doi. 10.3390/ijms23105807
- By:
- Publication type:
- Article
Establishment of an In Vivo Xenograft Mouse Model of a Subcutaneous Submillimeter HT-29 Tumor Formed from a Single Spheroid Transplanted Using Radiation-Crosslinked Gelatin Hydrogel Microwell.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 15, p. 7031, doi. 10.3390/app11157031
- By:
- Publication type:
- Article
Efficacy of vorinostat-sensitized intraperitoneal radioimmunotherapy with <sup>64</sup>Cu-labeled cetuximab against peritoneal dissemination of gastric cancer in a mouse model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Oral 'hydrogen water' induces neuroprotective ghrelin secretion in mice.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep03273
- By:
- Publication type:
- Article
The Long-Term Spontaneous Course of a Severe Traumatic Brain Injury Incurred at Age 16 by a 47-Year-Old Physician: Investigation into Planning a Long-Term Prognosis Study of Childhood Traumatic Brain Injury.
- Published in:
- International Medical Journal, 2012, v. 19, n. 4, p. 321
- By:
- Publication type:
- Article
An In Vivo Dual-Observation Method to Monitor Tumor Mass and Tumor-Surface Blood Vessels for Developing Anti-Angiogenesis Agents against Submillimeter Tumors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 24, p. 17234, doi. 10.3390/ijms242417234
- By:
- Publication type:
- Article